Drug Formulations with >12% Alcohol Now Require Doctor's Prescription

The Ministry of Health has amended the Drugs Rules, imposing new requirements for oral medicinal formulations containing more than 12% ethyl alcohol sold in bottles larger than 30 ml—these now require a doctor's prescription and cannot be sold over-the-counter. This represents a significant policy shift in regulating medicinal alcohol usage and addressing substance abuse.

Background: Cough syrups, tonics, and certain Ayurvedic preparations traditionally contained high alcohol content for preservation and bioavailability enhancement. However, these products became vehicles for alcohol misuse—particularly among adolescents and vulnerable populations seeking intoxication. The 'India Cough Syrup' crisis of 2012 (diethylene glycol contamination deaths) and subsequent abuse incidents prompted regulatory scrutiny. States like Kerala and Karnataka had already implemented restrictions; this is national harmonization.

Key provisions: (1) Prescription requirement for formulations >12% alcohol; (2) 30 ml bottle size threshold; (3) Potential impact on traditional medicine (Ayurveda, Unani) formulations; (4) Pharmacy and chemist compliance requirements; (5) Enforcement through State Drug Controllers.

Implications: Public health measure addressing substance abuse while protecting legitimate medicinal use. Balances traditional medicine heritage with modern regulatory frameworks. For UPSC: drug regulation, public health policy, federalism in health administration, traditional medicine integration, and regulatory impact on industry.